{
  "ticker": "IBX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976454",
  "id": "02976454",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250804",
  "time": "0935",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250804/pdf/06mhk5ldxqk91k.pdf",
  "summary": "- **Announcement Type**: Capital Raising (Placement)  \n- **Total Securities to be Issued**: 45,000,000 ordinary fully paid shares (ASX: IBX)  \n- **Issue Price**: AUD 0.015 per share  \n- **Proposed Issue Date**: 6 August 2025  \n- **Use of Proceeds**: Fund advancement of MagSense\u00ae technology (HER2 Breast Cancer) and Phase 1 clinical programs for prostate/ovarian cancer.  \n- **Placement Structure**:  \n  - 25.3M shares issued under 15% placement capacity (Listing Rule 7.1)  \n  - 19.7M shares issued under additional 10% capacity (Listing Rule 7.1A)  \n- **Broker**: CPS Capital Group Pty Ltd (2% management fee + 4% capital raising fee, payable in cash or shares).  \n- **No underwriting or security holder approval required**.  \n\n*Omitted: Legal boilerplate, routine disclaimers, and non-material fees.*",
  "usage": {
    "prompt_tokens": 1932,
    "completion_tokens": 219,
    "total_tokens": 2151,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-04T00:02:38.049689"
}